MENU
VRDN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Viridian Therapeutics (VRDN) Ownership - Who owns Viridian Therapeutics?

Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease... Show more

Industry: #Biotechnology

Profile

Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
94
Web
https://www.viridiantherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.71B
P/E Ratio
N/A
Total Cash
762.18M
Projected Growth
N/A
Total Debt
51.17M
Revenue
70.92M
Risk (Beta)
1.77
Dividend Yield
N/A
Total Cash/Share
7.39
Total Debt/Equity
N/A
Revenue/Share
0.79 USD as % of share price
View a ticker or compare two or three
VRDN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
221 Crescent Street
Phone
+1 617 272-4600
Employees
94
Web
https://www.viridiantherapeutics.com